A CPMP opinion for chlormezanone, pursuant to Article 12 of Council Directive 75/ 319/ EEC as amended, was adopted on 22 January 1997 (Annex B) recommending that the EU Marketing Authorisations of all chlormezanone-containing medicinal products should be withdrawn.